Astellas Pharma Inc
![Astellas Pharma Inc](https://api.admiralmarkets.com/trade_icons/bright-128/4503.png)
Open
1,688 1.38
Overview
Share price change
24h
Min
1666
Max
1697
Income | -48B -33B |
---|---|
Sales | -49B 373B |
P/E Sector Avg | 620.75 |
EPS | 4.33 |
Profit margin | -8.916 |
EBITDA | -62B 4.2B |
Next Earnings | 1 Aug 2024 |
---|---|
Next Ex Dividend date | 26 Sept 2024 |
Market Cap | 120B 3T |
---|---|
Previous open | 1686.62 |
Previous close | 1688 |
News Sentiment
By Acuity
49%
51%
Astellas Pharma Inc Chart
Related News
Astellas Pharma Inc Forecast
Sentiment
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
EBITDA
Operating profit
$
About Astellas Pharma Inc
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.